Evolution Wealth Management Inc.

SEC CIK: 0002010029
Latest filing: Jul 21, 2026

SEC filings (opens in a new tab)

CPRX holding history

Catalyst Pharmaceuticals, Inc. in every 13F filed by Evolution Wealth Management Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CPRX overview All 13F holders of CPRX Full Q2 2026 holdings

Shares (Q2 2026): 136
Value: $4.27K
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2025

Holdings of CPRX by Evolution Wealth Management Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	136	$4.27K	<0.1%	00.0%	Unchanged	Holders
Q1 2026	136	$3.37K	<0.1%	00.0%	Unchanged	Holders
Q4 2025	136	$3.17K	<0.1%	+136	New	Holders